Male C57BL/6J mice were given chronic ethanol treatment by two procedures. One was by a liquid diet containing 6.4% (v/v) ethanol; the other was by repeated injections of ethanol (3.5 g/kg, i.p. twice daily). After 5 days of the liquid diet treatment, sleep time following a challenge dose of ethanol (3.0 g/kg i.p.) was reduced to 10 min as compared with 30 min in the controls not previously exposed to ethanol. After 10 days, none of the ethanol-treated animals slept. Bilateral adrenalectomy (Adx) had no effect on sleep time (34 min). However, the reduction of sleep time in ethanol-treated Adx animals was much less: 19 min after 5 days, and 20 min after 10 days. Replacement with corticosterone in Adx animals restored the reduction of sleep time to the same levels as intact animals, indicating that glucocorticoids are the hormonal factor involved in the Adx effect. By the injection procedure for short-term administration of moderate doses of ethanol, sleep time following the injection of 3.5 g/kg ethanol was reduced from 95 min on day 1 to 57 min on day 3. There was no difference between intact and Adx animals. The results from both treatment procedures suggest that Adx abolished the later, severe stage of tolerance development but not the initial stage. Functional tolerance to ethanol occurring in this advanced stage may be a glucocorticoid-dependent process.

Keywords:
Ethanol, Tolerance, Sleep time, Glucocorticoids
This content is only available via PDF.
© 1983 S. Karger AG, Basel
1983
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.